CD274 and neoplasm: More MBC samples demonstrated CD163+ cells in the stroma (96.3% vs. 79.8%, p = 0.0468) and positive PD-L1 expression in tumor cells (29.6% vs. 10.1%, p = 0.0133) compared to TNBC samples.